WHO ICTRP trial

The value of Platelet-Rich Plasma injections in the treatment of the jumper's…

NL-OMON37132 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting

Key facts

Trial ID NL-OMON37132
Public title The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial
Scientific title The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial - PRP for the jumper's knee
Primary sponsor Meander Medisch Centrum
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Recruiting
Study type Interventional
Phase 3
Countries Netherlands
Conditions jumper's knee and apexitis;10043237;jumper's knee and apexitis
Interventions 27 cc of blood will be collected from all patients from the antecubital fossa to obtain 3 cc of PRP, using the mini GPS II system of Biomet. Preparation time will be 15 minutes. Then local anaesthesia will be applied using lidocaine. After…
Registration date Jan 24, 2011
Target size 90
Secondary IDs NL23993.100.08
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations